Australia markets closed

Sumitomo Pharma Co., Ltd. (DPM.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
3.9200-0.0400 (-1.01%)
As of 08:01AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
314,558,000
314,558,000
555,544,000
560,035,000
515,952,000
-
Cost of revenue
126,577,000
126,577,000
178,919,000
157,127,000
137,773,000
-
Gross profit
187,981,000
187,981,000
376,625,000
402,908,000
378,179,000
-
Operating expenses
Research development
112,637,000
112,637,000
131,858,000
94,903,000
132,682,000
-
Selling general and administrative
429,538,000
429,538,000
373,316,000
249,081,000
190,373,000
-
Total operating expenses
542,840,000
542,840,000
453,604,000
342,674,000
306,955,000
-
Operating income or loss
-354,859,000
-354,859,000
-76,979,000
60,234,000
71,224,000
-
Interest expense
4,277,000
4,277,000
3,159,000
3,050,000
2,586,000
-
Income before tax
-323,114,000
-323,114,000
-47,920,000
82,961,000
77,851,000
-
Income tax expense
-8,185,000
-8,185,000
48,794,000
42,361,000
41,022,000
-
Income from continuing operations
-314,929,000
-314,929,000
-96,714,000
40,600,000
36,829,000
-
Net income
-314,969,000
-314,969,000
-74,512,000
56,413,000
56,219,000
-
Net income available to common shareholders
-314,969,000
-314,969,000
-74,512,000
56,413,000
56,219,000
-
Basic EPS
168.72
-
-187.55
141.99
141.50
102.58
Diluted EPS
168.72
-
-187.55
141.99
141.50
102.58
Basic average shares
397,294
-
397,292
397,293
397,294
397,295
Diluted average shares
397,295
-
397,292
397,293
397,294
397,295